CathWorks develops medical devices for the interventional cardiology market.
The company’s technology is based on processing visual information and automatic multi-layered algorithms.
CathWorks’ technology is focused on improving the utilization of coronary angiography data to ratify measurement-based medicine in the cath lab.
CathWorks is a privately-held Israeli company established in 2013. It is supported by a dominant strategic partner as well as leading venture capital firms in the medical devices arena.